Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
2235.HK Stock Summary
Top 10 Correlated ETFs
2235.HK
In the News
2235.HK Financial details
Company Rating
Neutral
Market Cap
1.69B
Income
-45.76M
Revenue
212.53M
Book val./share
5.15
Cash/share
4.82
Dividend
-
Dividend %
-
Employees
742
Optionable
No
Shortable
Yes
Earnings
27 Mar 2024
P/E
-55.68
Forward P/E
-
PEG
32.03
P/S
12.58
P/B
0.95
P/C
0.87
P/FCF
-15.89
Quick Ratio
25.02
Current Ratio
26.61
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
-0.11
EPS next Y
0
EPS next Q
-
EPS this Y
-31.77%
EPS next Y
-104.26%
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-20%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-2%
ROE
-2%
ROC
-0.01%
Gross Margin
46%
Oper. Margin
-19%
Profit Margin
-22%
Payout
-
Shs Outstand
436.36M
Shs Float
230.14M
-
-
-
-
Target Price
-
52W Range
3.4-7.75
52W High
-40.29%
52W Low
+39.33%
RSI
46
Rel Volume
28.62
Avg Volume
106.1K
Volume
3.04M
Perf Week
1.21%
Perf Month
-4.57%
Perf Quarter
0.24%
Perf Half Y
-2.34%
-
-
-
-
Beta
0.724
-
-
Volatility
0.06%, 0.11%
Prev Close
4.24%
Price
4.18
Change
4.24%
2235.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.12 | 0.18 | 0.41 | 0.41 | |
Net income per share | -0.17 | -0.27 | -0.13 | -0.09 | |
Operating cash flow per share | -0.04 | -0.02 | -0.12 | -0.25 | |
Free cash flow per share | -0.11 | -0.08 | -0.17 | -0.32 | |
Cash per share | 0.39 | 1.55 | 5.76 | 4.81 | |
Book value per share | 0.51 | 1.72 | 6.02 | 5.2 | |
Tangible book value per share | 0.47 | 1.69 | 5.98 | 5.17 | |
Share holders equity per share | 0.51 | 1.72 | 6.02 | 5.2 | |
Interest debt per share | 0.02 | 0 | 0 | 0 | |
Market cap | 11.53B | 10.87B | 7.74B | 3.67B | |
Enterprise value | 11.5B | 10.32B | 5.59B | 1.62B | |
P/E ratio | -156.05 | -94.11 | -160.55 | -97.12 | |
Price to sales ratio | 222.4 | 144.4 | 51.09 | 21.12 | |
POCF ratio | -642.43 | -1.14K | -174.95 | -34.04 | |
PFCF ratio | -237.96 | -308.3 | -122.91 | -26.67 | |
P/B Ratio | 53.2 | 14.92 | 3.44 | 1.66 | |
PTB ratio | 53.2 | 14.92 | 3.44 | 1.66 | |
EV to sales | 221.79 | 137.1 | 36.89 | 9.33 | |
Enterprise value over EBITDA | -143.99 | -85.11 | -140.36 | -74.61 | |
EV to operating cash flow | -640.68 | -1.08K | -126.31 | -15.04 | |
EV to free cash flow | -237.31 | -292.71 | -88.74 | -11.79 | |
Earnings yield | -0.01 | -0.01 | -0.01 | -0.01 | |
Free cash flow yield | 0 | 0 | -0.01 | -0.04 | |
Debt to equity | 0.05 | 0 | 0 | 0 | |
Debt to assets | 0.04 | 0 | 0 | 0 | |
Net debt to EBITDA | 0.39 | 4.53 | 54.05 | 94.23 | |
Current ratio | 4.08 | 14.12 | 27.12 | 26.61 | |
Interest coverage | -267.9 | -411.52 | -2.83K | -219.01 | |
Income quality | 0.23 | 0.08 | 0.92 | 3.07 | |
Dividend Yield | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.04 | 0.08 | 0.28 | 0.24 | |
Research and developement to revenue | 0.97 | 1.09 | 0.1 | 0.18 | |
Intangibles to total assets | 0.06 | 0.02 | 0.01 | 0.01 | |
Capex to operating cash flow | 1.7 | 2.68 | 0.42 | 0.28 | |
Capex to revenue | -0.59 | -0.34 | -0.12 | -0.17 | |
Capex to depreciation | -8.9 | -4.68 | -2.25 | -2.84 | |
Stock based compensation to revenue | 1.11 | 1.48 | 0.08 | 0 | |
Graham number | 1.42 | 3.25 | 4.18 | 3.22 | |
ROIC | -0.35 | -0.17 | -0.02 | -0.02 | |
Return on tangible assets | -0.3 | -0.15 | -0.02 | -0.02 | |
Graham Net | 0.3 | 1.47 | 5.64 | 4.8 | |
Working capital | 147.6M | 639.52M | 2.15B | 2.1B | |
Tangible asset value | 200.66M | 714.06M | 2.23B | 2.2B | |
Net current asset value | 147.6M | 639.52M | 2.15B | 2.09B | |
Invested capital | 0.05 | 0 | 0 | 0 | |
Average receivables | 0 | 8.87M | 19.06M | 44.23M | |
Average payables | 0 | 6.42M | 10.86M | 16.97M | |
Average inventory | 0 | 13.53M | 26.29M | 50.75M | |
Days sales outstanding | 51.98 | 50.23 | 66.95 | 127.63 | |
Days payables outstanding | 68.95 | 71.61 | 63.98 | 77.09 | |
Days of inventory on hand | 113.49 | 173.61 | 154.87 | 261.78 | |
Receivables turnover | 7.02 | 7.27 | 5.45 | 2.86 | |
Payables turnover | 5.29 | 5.1 | 5.7 | 4.73 | |
Inventory turnover | 3.22 | 2.1 | 2.36 | 1.39 | |
ROE | -0.34 | -0.16 | -0.02 | -0.02 | |
Capex per share | -0.07 | -0.06 | -0.05 | -0.07 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0.12 | 0.12 | 0.13 | 0.13 | |
Net income per share | 0 | -0.03 | -0.03 | -0.02 | -0.02 | |
Operating cash flow per share | 0 | -0.1 | -0.1 | -0.04 | -0.04 | |
Free cash flow per share | 0 | -0.11 | -0.11 | -0.04 | -0.04 | |
Cash per share | 0 | 4.81 | 4.81 | 4.82 | 4.82 | |
Book value per share | 0 | 5.2 | 5.2 | 5.15 | 5.15 | |
Tangible book value per share | 0 | 5.17 | 5.17 | 5.11 | 5.11 | |
Share holders equity per share | 0 | 5.2 | 5.2 | 5.15 | 5.15 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 2.8B | 3.67B | 2.78B | 2.1B | |
Enterprise value | -2.1B | 751.05M | 1.62B | 732.87M | 53.74M | |
P/E ratio | 0 | -51.61 | -67.63 | -74.59 | -56.39 | |
Price to sales ratio | 0 | 55.01 | 72.08 | 50.25 | 37.99 | |
POCF ratio | 0 | -68.89 | -90.27 | -175.1 | -132.38 | |
PFCF ratio | 0 | -57.7 | -75.61 | -155.45 | -117.52 | |
P/B Ratio | 0 | 1.26 | 1.66 | 1.27 | 0.96 | |
PTB ratio | 0 | 1.26 | 1.66 | 1.27 | 0.96 | |
EV to sales | 0 | 14.77 | 31.85 | 13.23 | 0.97 | |
Enterprise value over EBITDA | 0 | -16.5 | -35.59 | -22.63 | -1.66 | |
EV to operating cash flow | 0 | -18.49 | -39.89 | -46.09 | -3.38 | |
EV to free cash flow | 0 | -15.49 | -33.41 | -40.92 | -3 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | -0.02 | -0.01 | -0.01 | -0.01 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 0 | 44.96 | 44.95 | 63.33 | 63.33 | |
Current ratio | 28.61 | 26.61 | 26.61 | 32.11 | 32.11 | |
Interest coverage | 0 | 0 | -601.79 | 0 | -734.35 | |
Income quality | 0 | 3 | 3 | 1.7 | 1.7 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.27 | 0.27 | 0.2 | 0.2 | |
Research and developement to revenue | 0 | 0.36 | 0.36 | 0.29 | 0.29 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | 0 | 0.19 | 0.19 | 0.13 | 0.13 | |
Capex to revenue | 0 | -0.15 | -0.15 | -0.04 | -0.04 | |
Capex to depreciation | 0 | -3.04 | -3.04 | -2.42 | -2.42 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 1.93 | 1.93 | 1.59 | 1.59 | |
ROIC | 0 | -0.02 | -0.02 | -0.02 | -0.02 | |
Return on tangible assets | 0 | -0.01 | -0.01 | 0 | 0 | |
Graham Net | 0 | 4.78 | 4.8 | 4.77 | 4.79 | |
Working capital | 2.14B | 2.1B | 2.1B | 2.08B | 2.08B | |
Tangible asset value | 2.23B | 2.2B | 2.2B | 2.18B | 2.18B | |
Net current asset value | 2.14B | 2.09B | 2.09B | 2.08B | 2.08B | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 24.63M | 54.97M | 46.99M | 38.71M | |
Average payables | 0 | 21.23M | 19.83M | 19.87M | 19.9M | |
Average inventory | 0 | 64.16M | 67.34M | 60.01M | 52.69M | |
Days sales outstanding | 0 | 87.16 | 107.39 | 54.07 | 71.69 | |
Days payables outstanding | 0 | 66.3 | 66.3 | 67.34 | 67.34 | |
Days of inventory on hand | 0 | 225.13 | 225.13 | 178.26 | 178.26 | |
Receivables turnover | 0 | 1.03 | 0.84 | 1.66 | 1.26 | |
Payables turnover | 0 | 1.36 | 1.36 | 1.34 | 1.34 | |
Inventory turnover | 0 | 0.4 | 0.4 | 0.5 | 0.5 | |
ROE | 0 | -0.01 | -0.01 | 0 | 0 | |
Capex per share | 0 | -0.02 | -0.02 | 0 | 0 |
2235.HK Frequently Asked Questions
What is MicroTech Medical (Hangzhou) Co., Ltd. stock symbol ?
MicroTech Medical (Hangzhou) Co., Ltd. is a CN stock and trading under the symbol 2235.HK
What is MicroTech Medical (Hangzhou) Co., Ltd. stock quote today ?
MicroTech Medical (Hangzhou) Co., Ltd. stock price is $4.18 today.
Is MicroTech Medical (Hangzhou) Co., Ltd. stock public?
Yes, MicroTech Medical (Hangzhou) Co., Ltd. is a publicly traded company.